Focal segmental glomerulosclerosis diagnostic study of choice: Difference between revisions
(Created page with "__NOTOC__ {{Focal segmental glomerulosclerosis}} {{CMG}}; {{AE}} == Overview == == Diagnostic Study of Choice == === Study of choice === * [Name of the investigation] is the...") |
|||
| Line 5: | Line 5: | ||
== Diagnostic Study of Choice == | == Diagnostic Study of Choice == | ||
===Renal Biopsy & Electron Microscopy=== | |||
Renal biopsy and electron microscopy are required for the diagnosis and management of FSGS.<ref name="pmid23871408">{{cite journal| author=Beck L, Bomback AS, Choi MJ, Holzman LB, Langford C, Mariani LH et al.| title=KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis. | journal=Am J Kidney Dis | year= 2013 | volume= 62 | issue= 3 | pages= 403-41 | pmid=23871408 | doi=10.1053/j.ajkd.2013.06.002 | pmc= |url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23871408 }} </ref> | |||
Kidney biopsy is the gold standard to establish the diagnosis of FSGS and determine the subtype of FSGS (see the histological variants of FSGS above). Kidney biopsy will reveal the presence of sclerosis in parts (segmental) of some (focal) glomeruli by light microscopy and diffuse (more than 80 percent) effacement of the foot processes by electron microscopy. | |||
=== Study of choice === | === Study of choice === | ||
| Line 77: | Line 81: | ||
IF there are no established diagnostic criteria: | IF there are no established diagnostic criteria: | ||
*There are no established criteria for the diagnosis of [disease name]. | *There are no established criteria for the diagnosis of [disease name]. | ||
==References== | ==References== | ||
Latest revision as of 15:55, 11 June 2018
|
Focal segmental glomerulosclerosis Microchapters |
|
Differentiating Focal segmental glomerulosclerosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Focal segmental glomerulosclerosis diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Focal segmental glomerulosclerosis diagnostic study of choice |
|
FDA on Focal segmental glomerulosclerosis diagnostic study of choice |
|
CDC on Focal segmental glomerulosclerosis diagnostic study of choice |
|
Focal segmental glomerulosclerosis diagnostic study of choice in the news |
|
Blogs on Focal segmental glomerulosclerosis diagnostic study of choice |
|
Directions to Hospitals Treating Focal segmental glomerulosclerosis |
|
Risk calculators and risk factors for Focal segmental glomerulosclerosis diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Diagnostic Study of Choice
Renal Biopsy & Electron Microscopy
Renal biopsy and electron microscopy are required for the diagnosis and management of FSGS.[1]
Kidney biopsy is the gold standard to establish the diagnosis of FSGS and determine the subtype of FSGS (see the histological variants of FSGS above). Kidney biopsy will reveal the presence of sclerosis in parts (segmental) of some (focal) glomeruli by light microscopy and diffuse (more than 80 percent) effacement of the foot processes by electron microscopy.
Study of choice
- [Name of the investigation] is the gold standard test for the diagnosis of [disease name].
- The following result of [gold standard test] is confirmatory of [disease name]:
- Result 1
- Result 2
- The [name of the investigation] should be performed when:
- The patient presented with symptoms/signs 1. 2, 3.
- A positive [test] is detected in the patient.
- [Name of the investigation] is the gold standard test for the diagnosis of [disease name].
- The diagnostic study of choice for [disease name] is [name of the investigation].
- There is no single diagnostic study of choice for the diagnosis of [disease name].
- There is no single diagnostic study of choice for the diagnosis of [disease name], but [disease name] can be diagnosed based on [name of the investigation 1] and [name of the investigation 2].
- [Disease name] is mainly diagnosed based on clinical presentation.
- Investigations:
- Among patients who present with clinical signs of [disease name], the [investigation name] is the most specific test for the diagnosis.
- Among patients who present with clinical signs of [disease name], the [investigation name] is the most sensitive test for diagnosis.
- Among patients who present with clinical signs of [disease name], the [investigation name] is the most efficient test for diagnosis.
The comparison of various diagnostic studies for [disease name]
| Test | Sensitivity | Specificity |
|---|---|---|
| Test 1 | ✔ | ...% |
| Test 2 | ...% | ✔ |
✔= The best test based on the feature
Diagnostic results
The following result of [investigation name] is confirmatory of [disease name]:
- Result 1
- Result 2
Sequence of Diagnostic Studies
The [name of investigation] should be performed when:
- The patient presented with symptoms/signs 1, 2, and 3 as the first step of diagnosis.
- A positive [test] is detected in the patient, to confirm the diagnosis.
Diagnostic Criteria
- Here you should describe the details of the diagnostic criteria.
- Always mention the name of the criteria/definition you are about to list (e.g. modified Duke criteria for the diagnosis of endocarditis / 3rd universal definition of MI) and cite the primary source of where this criteria/definition is found.
- Although not necessary, it is recommended that you include the criteria in a table. Make sure you always cite the source of the content and whether the table has been adapted from another source.
- Be very clear as to the number of criteria (or threshold) that needs to be met out of the total number of criteria.
- Distinguish criteria based on their nature (e.g. clinical criteria / pathological criteria/ imaging criteria) before discussing them in details.
- To view an example (endocarditis diagnostic criteria), click here
- If relevant, add additional information that might help the reader distinguish various criteria or the evolution of criteria (e.g. original criteria vs. modified criteria).
- You may also add information about the sensitivity and specificity of the criteria, the pre-test probability, and other figures that may help the reader understand how valuable the criteria are clinically.
- [Disease name] is mainly diagnosed based on clinical presentation. There are no established criteria for the diagnosis of [disease name].
- There is no single diagnostic study of choice for [disease name], though [disease name] may be diagnosed based on [name of criteria] established by [...].
- The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].
- The diagnosis of [disease name] is based on the [criteria name] criteria, which includes [criterion 1], [criterion 2], and [criterion 3].
- [Disease name] may be diagnosed at any time if one or more of the following criteria are met:
- Criteria 1
- Criteria 2
- Criteria 3
IF there are clear, established diagnostic criteria:
- The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].
- The diagnosis of [disease name] is based on the [criteria name] criteria, which include [criterion 1], [criterion 2], and [criterion 3].
- The diagnosis of [disease name] is based on the [definition name] definition, which includes [criterion 1], [criterion 2], and [criterion 3].
IF there are no established diagnostic criteria:
- There are no established criteria for the diagnosis of [disease name].
References
- ↑ Beck L, Bomback AS, Choi MJ, Holzman LB, Langford C, Mariani LH; et al. (2013). "KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis". Am J Kidney Dis. 62 (3): 403–41. doi:10.1053/j.ajkd.2013.06.002. PMID 23871408.